SCHEMBL5477167

SCHEMBL5477167

N#Cc1ccc2oc3c(C4CCCC4)c(O)ccc3c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.36
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ CHRM5 P08912 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ CHRM3 P20309 1/20 0.34
▸ SLC6A4 P31645 3/20 0.32
▸ FAAH O00519 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ PIM3 Q86V86 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ HRH3 Q9Y5N1 2/20 0.31
▸ AR P10275 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5483895 0.82 HRH4 (0.37) HRH4PTGDR2KDM1AARLRRK2
SCHEMBL13564574 0.76 CYP2A6 (0.44) HRH4SLC6A4PIM1CSNK2A2CSNK2B
SCHEMBL5475607 0.73 HRH4 (0.34) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL1260698 0.69 DRD3 (0.35) PTGDR2CHRM2CHRM4CHRM5CHRM1
SCHEMBL5471761 0.69 GUSB (0.33) HRH4PIM1CSNK2A2CSNK2BPIM3
SCHEMBL548410 0.69 CYP2A6 (0.50) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL4878052 0.68 PTGDR2 (0.55) PTGDR2KDM1AMAOADRD2DRD3
SCHEMBL1636266 0.68 TBK1 (0.43) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL11554110 0.66 CYP2A6 (0.44) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL5471196 0.66 KDM4E (0.60) CSNK2A2CSNK2BMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 — — US claimed
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093548-A1 Use of progesterone receptor modulators PGR, GNRHR, PGRMC2 HRH4 1091/4885PTGDR2 28/4885CHRM2 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback